Please use this identifier to cite or link to this item:
Title: Intravitreal moxifloxacin in treatment of postcataract endophthalmitis
Authors: Ayash, Jad G.
Wahab, Charbel H.
Sammouh, Fady K.
Warrak, Elias L.
Affiliations: Faculty of Medicine 
Issue Date: 2021-01-01
Part of: JCRS Online Case Reports
Volume: 9
Issue: 2
Postcataract endophthalmitis is a well-known and feared complication that might lead to a devastating outcome for the diseased eye. A case of postcataract extraction endophthalmitis treated with an intravitreal moxifloxacin injection prepared from commercially available preservative-free topical eyedrops (Vigamox), achieving 20/20 corrected distance visual acuity posttreatment is reported. A 70-year-old woman was found to have endophthalmitis in the left eye with hand motion vision on day 8 postcataract extraction. Accordingly, tap-and-inject procedure was performed using 0.05 mL of 0.5% moxifloxacin aspirated directly from a sealed eyedrop bottle and injected intravitreally. Forty-eight hours later, a similar second injection was given. The patient improved progressively and reached 20/20 vision 2 months later.
DOI: 10.1097/j.jcro.0000000000000046
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Record view(s)

checked on Apr 22, 2024

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.